Cheyne Capital Management (UK)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-17,115
Closed -$793K 43
2022
Q4
$793K Buy
+17,115
New +$793K 1.39% 28